These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 4211751)

  • 21. [Physiopathology of disseminated intravascular coagulation].
    Pudlák P
    Cas Lek Cesk; 1971 Sep; 110(37):860-3. PubMed ID: 5098741
    [No Abstract]   [Full Text] [Related]  

  • 22. The relevance of blood clotting tests in chronic aggressive hepatitis.
    Coccheri S; Gasbarrini G
    Scand J Gastroenterol Suppl; 1973; 19():97-101. PubMed ID: 4515645
    [No Abstract]   [Full Text] [Related]  

  • 23. The in vivo behavior of the terminal derivatives of fibrinogen and fibrin cleaved by plasmin.
    Catanzaro A; Edgington TS
    J Lab Clin Med; 1974 Mar; 83(3):458-66. PubMed ID: 4272970
    [No Abstract]   [Full Text] [Related]  

  • 24. Disseminated intravascular coagulation and the balance between blood coagulation and fibrinolysis.
    Astrup T; Jespersen J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):407-15. PubMed ID: 6083904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hemostatic system disorders in malaria (a review of the literature)].
    Bronshteĭn AM
    Med Parazitol (Mosk); 1981; 50(4):64-72. PubMed ID: 7024773
    [No Abstract]   [Full Text] [Related]  

  • 26. Disseminated intravascular coagulation and renal failure: Production in the monkey with autologous red blood cell stroma.
    Birndorf NI; Lopas H; Robboy SJ
    Lab Invest; 1971 Oct; 25(4):314-9. PubMed ID: 5000483
    [No Abstract]   [Full Text] [Related]  

  • 27. Progress in the measurement of circulating fibrinogen derivatives.
    Wilner GD
    Prog Clin Pathol; 1984; 9():15-45. PubMed ID: 6229812
    [No Abstract]   [Full Text] [Related]  

  • 28. Elimination of iodine-labelled fibrinogen in intravascular coagulation and in the normal state. Experimental and clinical studies.
    Zetterqvist E
    Acta Physiol Scand Suppl; 1969; 325():1-41. PubMed ID: 4900570
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparative biochemistry of hemoglobins. 3. On the difference between Macaca mulatta monkey hemoglobin and human hemoglobin.
    Shikaya T
    Acta Med Nagasaki; 1966 Mar; 10(3):77-91. PubMed ID: 4960107
    [No Abstract]   [Full Text] [Related]  

  • 30. [Diagnostic significance of the analysis of fibrinogen derivatives].
    Schwabe G; Heene DL; Krause W
    Verh Dtsch Ges Inn Med; 1972; 78():719-23. PubMed ID: 4665740
    [No Abstract]   [Full Text] [Related]  

  • 31. [Measurement of fibrinogen degradation products: its usefulness in consumption coagulopathies].
    Thuot C; Perron L
    Union Med Can; 1973 Jan; 102(1):66-9. PubMed ID: 4706340
    [No Abstract]   [Full Text] [Related]  

  • 32. Metabolism of 131 I-labelled fibrinogen in monkeys infected with Plasmodium coatneyi.
    Areekul S; Devakul K; Chongsuphajaisiddhi T; Vivatanasesth P; Kanakakorn K; Kasemsuth R
    Southeast Asian J Trop Med Public Health; 1971 Dec; 2(4):455-61. PubMed ID: 5004139
    [No Abstract]   [Full Text] [Related]  

  • 33. Fibrin detected in plasma of patients with disseminated intravascular coagulation by fibrin-specific antibodies consists primarily of high molecular weight factor XIIIa-crosslinked and plasmin-modified complexes partially containing fibrinopeptide A.
    Pfitzner SA; Dempfle CE; Matsuda M; Heene DL
    Thromb Haemost; 1997 Sep; 78(3):1069-78. PubMed ID: 9308756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The occurrence of fibrinogens of different molecular weights in disseminated intravascular coagulation.
    Holm B
    Scand J Clin Lab Invest Suppl; 1985; 178():155-7. PubMed ID: 3867117
    [No Abstract]   [Full Text] [Related]  

  • 35. Chronic intravascular coagulation. Clinical spectrum and diagnostic criteria, with special emphasis on metabolism, distribution and localization of I 131 -fibrinogen.
    Straub PW
    Acta Med Scand Suppl; 1971; 526():1-95. PubMed ID: 5292077
    [No Abstract]   [Full Text] [Related]  

  • 36. [Changes in clotting mechanism in consumption coagulopathy].
    Maekawa T; Suzuki Y; Kobayashi N; Ito T
    Rinsho Ketsueki; 1972 Apr; 13(2):167-76. PubMed ID: 4674796
    [No Abstract]   [Full Text] [Related]  

  • 37. [Studies on fibrinogen heterogeneity in disseminated intravascular coagulation].
    Yamauchi M
    Hokkaido Igaku Zasshi; 1982 Jul; 57(4):425-36. PubMed ID: 7173813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The importance of intermediate degradation products of fibrinogen in fibrinolytic hemorrhage.
    Marder VJ; Shulman NR; Carroll WR
    Trans Assoc Am Physicians; 1967; 80():156-67. PubMed ID: 4230117
    [No Abstract]   [Full Text] [Related]  

  • 39. Delayed lung lesion in dogs after thrombin-induced disseminated intravascular coagulation.
    Josephson S; Swedenborg J; Dahlgren SE
    Acta Chir Scand; 1974; 140(6):431-5. PubMed ID: 4428917
    [No Abstract]   [Full Text] [Related]  

  • 40. [Distinction between fibrinogen and fibrin degradation products in serum from patients with DIC (author's transl)].
    Yoshioka K; Yamamoto T; Yamauchi E; Mizuno S; Miyata H
    Rinsho Ketsueki; 1981 Sep; 22(9):1401-5. PubMed ID: 7334618
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.